Multi-stage chemical carcinogenesis in mouse skin: Fundamentals and applications

被引:405
作者
Abel, Erika L. [1 ]
Angel, Joe M. [1 ]
Kiguchi, Kaoru [1 ]
DiGiovanni, John [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Carcinogenesis, Div Sci Pk Res, Smithville, TX USA
关键词
SQUAMOUS-CELL CARCINOMA; ENHANCES MALIGNANT PROGRESSION; KERATINOCYTE STEM-CELLS; HARVEY-RAS GENE; TUMOR PROMOTION; SENCAR MICE; EPIDERMAL-KERATINOCYTES; 2-STAGE CARCINOGENESIS; C57BL/6; MICE; CYCLOOXYGENASE-2; OVEREXPRESSION;
D O I
10.1038/nprot.2009.120
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
For more than 60 years, the chemical induction of tumors in mouse skin has been used to study mechanisms of epithelial carcinogenesis and evaluate modifying factors. In the traditional two-stage skin carcinogenesis model, the initiation phase is accomplished by the application of a sub-carcinogenic dose of a carcinogen. Subsequently, tumor development is elicited by repeated treatment with a tumor-promoting agent. The initiation protocol can be completed within 1-3 h depending on the number of mice used; whereas the promotion phase requires twice weekly treatments (1-2 h) and once weekly tumor palpation (1-2 h) for the duration of the study. Using the protocol described here, a highly reproducible papilloma burden is expected within 10-20 weeks with progression of a portion of the tumors to squamous cell carcinomas within 20-50 weeks. In contrast to complete skin carcinogenesis, the two-stage model allows for greater yield of premalignant lesions, as well as separation of the initiation and promotion phases.
引用
收藏
页码:1350 / 1362
页数:13
相关论文
共 135 条
  • [21] Sequential down-regulation of E-cadherin with squamous cell carcinoma progression:: Loss of E-cadherin via a prostaglandin E2-EP2-dependent posttranslational mechanism
    Brouxhon, Sabine
    Kyrkanides, Stephanos
    O'Banion, M. Kerry
    Johnson, Renee
    Pearce, David A.
    Centola, Gina M.
    Miller, Jen-nie H.
    McGrath, Kieran H.
    Erdle, Brandon
    Scott, Glynis
    Schneider, Sandra
    VanBuskirk, JoAnne
    Pentland, Alice P.
    [J]. CANCER RESEARCH, 2007, 67 (16) : 7654 - 7664
  • [22] The malignant capacity of skin tumours induced by expression of a mutant H-ras transgene depends on the cell type targeted
    Brown, K
    Strathdee, D
    Bryson, S
    Lambie, W
    Balmain, A
    [J]. CURRENT BIOLOGY, 1998, 8 (09) : 516 - 524
  • [23] CARCINOGEN-INDUCED MUTATIONS IN THE MOUSE C-HA-RAS GENE PROVIDE EVIDENCE OF MULTIPLE PATHWAYS FOR TUMOR PROGRESSION
    BROWN, K
    BUCHMANN, A
    BALMAIN, A
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (02) : 538 - 542
  • [24] Casanova ML, 2002, CANCER RES, V62, P3402
  • [25] CHANGES IN KERATIN EXPRESSION DURING MALIGNANT PROGRESSION OF TRANSFORMED MOUSE EPIDERMAL-KERATINOCYTES
    CAULIN, C
    BAULUZ, C
    GANDARILLAS, A
    CANO, A
    QUINTANILLA, M
    [J]. EXPERIMENTAL CELL RESEARCH, 1993, 204 (01) : 11 - 21
  • [26] Forced expression of a constitutively active form of Stat3 in mouse epidermis enhances malignant progression of skin tumors induced by two-stage carcinogenesis
    Chan, K. S.
    Sano, S.
    Kataoka, K.
    Abel, E.
    Carbajal, S.
    Beltran, L.
    Clifford, J.
    Peavey, M.
    Shen, J.
    DiGiovanni, J.
    [J]. ONCOGENE, 2008, 27 (08) : 1087 - 1094
  • [27] Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis
    Chan, KS
    Sano, S
    Kiguchi, K
    Anders, J
    Komazawa, N
    Takeda, J
    DiGiovanni, J
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (05) : 720 - 728
  • [28] Genetically engineered mouse models for skin research: Taking the next step
    Chen, Jiang
    Roop, Dennis R.
    [J]. JOURNAL OF DERMATOLOGICAL SCIENCE, 2008, 52 (01) : 1 - 12
  • [29] CHIBA M, 1986, CANCER RES, V46, P259
  • [30] ANEUPLOIDY, AN EARLY EVENT IN MOUSE SKIN TUMOR-DEVELOPMENT
    CONTI, CJ
    ALDAZ, CM
    OCONNELL, J
    KLEINSZANTO, AJP
    SLAGA, TJ
    [J]. CARCINOGENESIS, 1986, 7 (11) : 1845 - 1848